According to Sanofi latest financial reports the cash on hand of SAN is $420.45B, an increase of 50.03% to 2022. At the end of 2022 company had $280.25B cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $420.45B | 50.03% |
2022 | $280.25B | 2.56% |
2021 | $273.26B | 38.26% |
2020 | $197.64B | -23.54% |
2019 | $258.47B | -3.83% |
2018 | $268.75B | - |